DK0817860T3 - Pseudotype retrovirale partikler - Google Patents
Pseudotype retrovirale partiklerInfo
- Publication number
- DK0817860T3 DK0817860T3 DK96909135T DK96909135T DK0817860T3 DK 0817860 T3 DK0817860 T3 DK 0817860T3 DK 96909135 T DK96909135 T DK 96909135T DK 96909135 T DK96909135 T DK 96909135T DK 0817860 T3 DK0817860 T3 DK 0817860T3
- Authority
- DK
- Denmark
- Prior art keywords
- retroviral particles
- retroviral vector
- virus
- mlv
- vector system
- Prior art date
Links
- 230000001177 retroviral effect Effects 0.000 title abstract 6
- 239000002245 particle Substances 0.000 title abstract 3
- 241000713333 Mouse mammary tumor virus Species 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- 230000002255 enzymatic effect Effects 0.000 abstract 1
- 238000002955 isolation Methods 0.000 abstract 1
- 238000004806 packaging method and process Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13051—Methods of production or purification of viral material
- C12N2740/13052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Communicable Diseases (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Optical Radar Systems And Details Thereof (AREA)
- Eye Examination Apparatus (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Developing Agents For Electrophotography (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK32795 | 1995-03-29 | ||
| PCT/EP1996/001348 WO1996030533A1 (en) | 1995-03-29 | 1996-03-27 | Pseudotyped retroviral particles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0817860T3 true DK0817860T3 (da) | 2001-10-01 |
Family
ID=8092296
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK96909135T DK0817860T3 (da) | 1995-03-29 | 1996-03-27 | Pseudotype retrovirale partikler |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0817860B1 (da) |
| JP (1) | JPH11502706A (da) |
| AT (1) | ATE200912T1 (da) |
| AU (1) | AU5274696A (da) |
| DE (1) | DE69612660T2 (da) |
| DK (1) | DK0817860T3 (da) |
| ES (1) | ES2157435T3 (da) |
| WO (1) | WO1996030533A1 (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11507244A (ja) * | 1995-10-05 | 1999-06-29 | カイロン コーポレイション | Ｓｒｖ−３エンベロープ糖タンパク質配列で偽型化したレトロウイルスベクター |
| EP0975783B1 (de) * | 1997-02-27 | 2001-10-31 | Bundesrepublik Deutschland, letztvertreten durch den Präsidenten des Paul-Ehrlich-Instituts | Retrovirale vektoren, verfahren zu ihrer herstellung und ihre verwendung zur genübertragung in cd4-positive zellen |
| EP0938904A1 (en) * | 1998-02-09 | 1999-09-01 | Leuven Research & Development vzw | Mammalian cell transduction for use in gene therapy |
| WO1998053063A2 (en) * | 1997-05-16 | 1998-11-26 | Leuven Research & Development Vzw | Mammalian cell transduction for use in gene therapy |
| FR2779445B1 (fr) * | 1998-06-08 | 2000-08-11 | Univ Nantes | Kit d'encapsidation |
| GB0400443D0 (en) | 2004-01-09 | 2004-02-11 | Oxford Biomedica Ltd | Cascade |
| JP2005503162A (ja) * | 2001-09-21 | 2005-02-03 | オックスフォード バイオメディカ（ユーケイ）リミテッド | ベクター |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69420033T2 (de) * | 1993-04-06 | 1999-12-23 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Bethesda | Gibbon leukemia virus retrovirale vektoren |
-
1996
- 1996-03-27 DE DE69612660T patent/DE69612660T2/de not_active Expired - Lifetime
- 1996-03-27 DK DK96909135T patent/DK0817860T3/da active
- 1996-03-27 JP JP8528928A patent/JPH11502706A/ja not_active Ceased
- 1996-03-27 EP EP96909135A patent/EP0817860B1/en not_active Expired - Lifetime
- 1996-03-27 ES ES96909135T patent/ES2157435T3/es not_active Expired - Lifetime
- 1996-03-27 AU AU52746/96A patent/AU5274696A/en not_active Abandoned
- 1996-03-27 WO PCT/EP1996/001348 patent/WO1996030533A1/en active IP Right Grant
- 1996-03-27 AT AT96909135T patent/ATE200912T1/de active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2157435T3 (es) | 2001-08-16 |
| ATE200912T1 (de) | 2001-05-15 |
| EP0817860B1 (en) | 2001-05-02 |
| JPH11502706A (ja) | 1999-03-09 |
| AU5274696A (en) | 1996-10-16 |
| DE69612660T2 (de) | 2002-04-18 |
| EP0817860A1 (en) | 1998-01-14 |
| DE69612660D1 (de) | 2001-06-07 |
| WO1996030533A1 (en) | 1996-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2331522A (en) | Lentiviral vectors | |
| DE69535669D1 (de) | Retrovirale vektoren mit verminderter rekombinationsrate | |
| ES2153654T3 (es) | Vectores retrovirales. | |
| DE69829471D1 (de) | Auf lentivirus basierende gentransfer-vektoren | |
| AU3988799A (en) | Novel lentiviral packaging cells | |
| FR2731013B1 (fr) | Vih-1 de groupe o, fragments desdits virus, ainsi que leurs applications | |
| DK0817860T3 (da) | Pseudotype retrovirale partikler | |
| NO975813L (no) | Innkapslede celler som produserer virale partikler | |
| TR200000182T2 (tr) | Yüksek etkinliğe sahip polietilen katalizörleri. | |
| Rawson et al. | Transcription start site heterogeneity and preferential packaging of specific full-length RNA species are conserved features of primate lentiviruses | |
| ATE422544T1 (de) | Nicht-m nicht-o hiv-1-stamm, fragmente und verwendungen | |
| WO2000040741A3 (en) | Lentivirus vector system | |
| ES2167072T3 (es) | Vectores retrovirales, procedimientos para su preparacion y su utilizacion para la transmision de genes a celulas cd-4 positivas. | |
| WO2002042482A3 (en) | Functional lentiviral vector from an mlv-based backbone | |
| WO1994020621A3 (en) | Proteinaceous particles containing retroviral element | |
| PT880594E (pt) | Vector retroviral e sua utilizacao em terapia genica | |
| NO20002013D0 (no) | Suspensjonsforpakningscellelinjer for retrovirusvektorer | |
| WO1995025806A3 (en) | Packaging-deficient lentiviruses | |
| AR020076A1 (es) | LíNEA CELULAR DE EMPAQUETAMIENTO DE RETROVIRUS ANFOTRoPICO, PROCESO PARA SU PRODUCCIoN, Y PROCESO PARA LA PRODUCCIoN DE UN VECTOR RETROVIRAL MEDIANTE LA MISMA. | |
| WO1999025862A3 (en) | Chimeric viral packaging signal without gag gene sequences | |
| AU1847597A (en) | Transduced human hematopoietic stem cells | |
| WO2002068625A3 (de) | Verpackungszellinie für lentivirale vektoren |